Caracterización clinicoepidemiológica de pacientes con tumores palpebrales malignos

Arias Soto, Julio Cesar; Santos Silva, Dania; García Gali, Madeline de Jesús; Ortiz Silveira, Marlene; Matienzo Vergara, Sulli de la Caridad
December 2012
MEDISAN;2012, Vol. 16 Issue 12, p56
Academic Journal
An observational, descriptive and cross-sectional study was conducted in 61 patients with malignant eyelid tumors, treated at the Ophthalmology Department of the National Institute of Oncology and Radiobiology, Havana, during 2011, in order to characterize them according to clinical and epidemiological variates of interest to research. Male sex (68.6%) and white patients (86.9%) were the most affected in the series. Also, the age group of 61-70 years (37.0%), basal cell epithelioma as the most frequent malignant eyelid tumor (73.8%) and agriculture as the essential work performed by patients (67.2%) prevailed.


Related Articles

  • New Research Reveals Non-Melanoma Skin Cancer Has Become an Epidemic.  // Dermatology Nursing;Jul/Aug2010, Vol. 22 Issue 4, p41 

    The article discusses two new studies which indicated that non-melanoma skin cancer has turned epidemic. It cites the study led by Howard Rogers which showed that more than two million people on Medicare have undergone treatment for non-melanoma skin cancer in 2006, and another study by Dr....

  • Sebaceous gland carcinoma of the eyelid. Wali, Upender K.; Al-Mujaini, Abdullah // Oman Journal of Ophthalmology;Sep2010, Vol. 3 Issue 3, p117 

    Sebaceous gland carcinoma, commonly arises in the periocular area, is an uncommon condition. It represents 1-5.5% of eyelid malignancies and is considered to be the third most common eyelid malignancy after basal cell and squamous cell carcinomas, although few reports placed this tumor as second...

  • Management of Eyelid Malignancies. Cook Jr., Briggs E. // Review of Ophthalmology;May2003, Vol. 10 Issue 5, p111 

    Describes the clinical characteristics of malignant eyelid tumors. Basal cell carcinoma; Squamous cell carcinoma; Sebaceous gland carcinoma; Malignant melanoma; Recommendations for therapy of the different types of malignant eyelid tumors.

  • Recognize malignant, benign lesions. Rivera-Michlig, Roxana; Meszaros, Liz // Ophthalmology Times;1/15/2013, Vol. 38 Issue 2, p35 

    The article offers information on a differential diagnostic study related to lesion development in the eyelids. It mentions that such lesions can be a result of both benign as well as malignant conditions and therefore an expert ophthalmic investigation is mandatory in such cases. Further it...

  • The molecular genetics of eyelid tumors: recent advances and future directions. Milman, Tatyana; McCormick, Steven // Graefe's Archive of Clinical & Experimental Ophthalmology;Feb2013, Vol. 251 Issue 2, p419 

    Background: Unprecedented recent advances in the molecular genetics of cutaneous malignancies have markedly improved our ability to diagnose, treat, and counsel patients with skin tumors. This review provides an update on molecular genetics of periocular cutaneous basal cell carcinoma, squamous...

  • Reconstrucción palpebral inferior después de la escisión de tumores malignos. Arias Soto, Julio Cesar; Abreu Perdomo, Franklin A.; Silveira, Marlene Ortiz; Delisle, Justo Despaigne; De la Caridad, Sulli; Vergara, Matienzo // MEDISAN;2013, Vol. 17 Issue 7, p2056 

    Four case reports of patients of 46-76 years with squamous-cell carcinoma and basalcell epithelioma of lower eyelid was described, diagnosed in the ophthalmology department of "Dr. Juan Bruno Zayas Alfonso" Teaching General Hospital. In those affected a partial or total tarsectomy with eyelid...

  • In the spotlight: skin cancers. McAvoy, Brian // New Zealand Doctor;2/10/2010, p14 

    The article presents information on the prevalence of the two types on non-melanoma skin cancers (NMSC), namely, the squamous cell carcinoma and the basal cell carcinoma, in New Zealand. The factors to consider when treating NMSC include size and location. Treatment recommendations include...

  • Core principles can help patients make informed decisions with confidence. Sobanko, Joseph F. // Hem/Onc Today;7/25/2013, Vol. 14 Issue 14, p29 

    The author comments on a report on the management of basal cell and squamous cell carcinomas at dermatology clinics in Northern California.

  • Concordance of Genetic Changes in Basal Cell Carcinoma and Associated Clusters of Squamous Cells. Boni, Roland; Vortmeyer, A.O.; Stern, J.B.; Burg, G.; Hotbauer, G.; Zhuang, Z. // Journal of Investigative Dermatology;Jul98, Vol. 111 Issue 1, p173 

    Discusses how the specificity of genetic changes in basal cell carcinomas (BCC) may prove useful to differentiate between different histologic areas in BCC associated with a squamous cell component. Cases; Results.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics